Catching up on some of the posts, took a big turn into Ivermectin for sure. I did see an interesting article on pubmed that suggests Ivermectin in combo with other drugs is worth looking at more (link below) but I saw elsewhere that after further analysis that FDA and CDC still not on board. I do agree that we have to exercise critical thinking when protecting our own health but when in question I still will put a lot more weight on the critical thinking of bio/health scientists and MDs as opposed to thoughts from those less qualified and outliers presenting anecdotal evidence. 

I also came across an interesting Bloomberg article strongly linking COVID to large increased risk for diabetes (link also below).  Sounds more and more like Apabetalone is made to have a big place as a COVID therapy.  Sure wish management would get something done.  Don needs some tutoring in remedial English if he thinks their performance is representative of going after this opportunity "hardcore" and that they were going to be enrolling trial patients almost "immediately" (February).  Anyway we still wait, really hope something is actually happening.  The share price indicates the market has zero faith in management or their words, perhaps that will change if they produce something positive and tangible.

https://pubmed.ncbi.nlm.nih.gov/33578014/

https://www.bloomberg.com/news/articles/2021-05-05/two-pandemics-clash-as-doctors-find-that-covid-spurs-diabetes